Nicole Huffman, MD
Dermatology · Northbrook, ILNPI 1740448927
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,958 of the $7,774 with a category attached, or 76.6%. AbbVie accounts for 82.0% of it on its own, with 26 other manufacturers making up the rest.
Across 115 payments — averaging $67.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Regeneron Healthcare Solutions, Inc.$276
- Sanofi$161
- Galderma Laboratories, L.p.$117
- Johnson & Johnson$109
- Prugen, Inc. Pharmaceuticals$103
- plus $630 from 21 others
What the payments were for
- Speaking & faculty fees$5,95877%
- Food & beverage$1,81123%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $6,376 |
| Regeneron Healthcare Solutions, Inc. | 10 | $276 |
| Sanofi | 5 | $161 |
| Galderma Laboratories, L.p. | 8 | $117 |
| Johnson & Johnson | 5 | $109 |
| Prugen, Inc. Pharmaceuticals | 1 | $103 |
| Novartis | 4 | $68 |
| Amgen | 3 | $65 |
| Pfizer | 4 | $62 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| UCB, Inc. | 2 | $44 |
| Dermira, Inc. | 2 | $35 |
| Dermavant Sciences, Inc. | 1 | $31 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Incyte Corporation | 1 | $27 |
| Organon | 1 | $26 |
| Bristol Myers Squibb | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $11 |
How this compares
$7,774 in reported general payments places this provider in the 75th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 24 | $1,854 |
| Metronidazole | 33 | $1,546 |
| Betamethasone Dipropionate | 50 | $1,442 |
| Ketoconazole | 64 | $972 |
| Doxycycline Hyclate | 35 | $966 |
| ValacyclovirValacyclovir Hcl | 37 | $953 |
| Clobetasol Propionate | 18 | $608 |
| Triamcinolone Acetonide | 101 | $598 |
| Nystatin | 41 | $530 |
| Imiquimod | 15 | $446 |
| Hydrocortisone | 22 | $180 |
| Mupirocin | 13 | $74 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Northbrook
- George LewittNorthbrook$3M
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Emily RubensteinLincolnshire$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.